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Abstract
Background: Congenital Bicuspid Aortic Valve (BAV) is a significant risk factor for serious complications including
valve dysfunction, aortic dilatation, dissection, and sudden death. Clinical tools for identification and monitoring of
BAV patients at high risk for development of aortic dilatation, an early complication, are not available.
Methods: This paper reports an investigation in 18 pediatric BAV patients and 10 normal controls of links between
abnormal blood flow patterns in the ascending aorta and aortic dilatation using velocity-encoded cardiovascular
magnetic resonance. Blood flow patterns were quantitatively expressed in the angle between systolic left
ventricular outflow and the aortic root channel axis, and also correlated with known biochemical markers of vessel
wall disease.
Results: The data confirm larger ascending aortas in BAV patients than in controls, and show more angled LV
outflow in BAV (17.54 ± 0.87 degrees) than controls (10.01 ± 1.29) (p = 0.01). Significant correlation of systolic LV
outflow jet angles with dilatation was found at different levels of the aorta in BAV patients STJ: r = 0.386 (N = 18, p
= 0.048), AAO: r = 0.536 (N = 18, p = 0.022), and stronger correlation was found with patients and controls
combined into one population: SOV: r = 0.405 (N = 28, p = 0.033), STJ: r = 0.562 (N = 28, p = 0.002), and AAO r =
0.645 (N = 28, p < 0.001). Dilatation and the flow jet angle were also found to correlate with plasma levels of
matrix metallo-proteinase 2.
Conclusions: The results of this study provide new insights into the pathophysiological processes underlying aortic
dilatation in BAV patients. These results show a possible path towards the development of clinical risk stratification
protocols in order to reduce morbidity and mortality for this common congenital heart defect.
Introduction
Bicuspid aortic valve (BAV) is the most common conge-
nital cardiovascular malformation with an estimated pre-
valence of 1-2% [1,2] in the general population, and is a
significant risk factor for several serious complications
including aortic dilatation and dissection [1,3,4]. An
association between aortic dilatation and BAV has been
confirmed in numerous studies [5-14] in comparisons
against normal controls. Aortic dilatation, initially
asymptomatic in BAV, often develops during childhood
[8,12,15]. Dilatation may be observed at different levels
in the aorta, but most commonly involves the ascending
aorta [14,16]. BAV patients with a dilated aorta have a
9-fold increased risk of aortic dissection [3,17] and have
an increased risk of sudden cardiac death, even after
valve replacement [18-20]. However, the progression of
aortic dilatation varies considerably between BAV
patients, ranging from normal size development to
severely dilated at early ages [12]. This complicates
accurate prognosis at the time of identification of the
lesion and cost-effective tailoring of follow-up
recommendations.
Even though the association between bicuspid aortic
valves and aortic dilatation is well known, clinical * Correspondence: mbrumme@emory.edu
4Emory University School of Medicine, Atlanta, Georgia, USA
den Reijer et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:4
http://www.jcmr-online.com/content/12/1/4
© 2010 den Reijer et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.predictors for the development and progression of aortic
dilatation are lacking. Abnormal blood flow patterns and
the consideration of BAV as part of a connective tissue
disease may be important factors, but their relative
importance remains unclear. Excised BAVs have been
shown associated with abnormal flow patterns and tur-
bulence aimed toward the right anterolateral wall (con-
vexity) of the aorta in flow loop experiments with
phantom models of aorta [21]. An echocardiographic
study involving aortic tissue Doppler has demonstrated
greater hemodynamic stress on the anterolateral ascend-
ing aorta [22]. Recently, the presence of abnormal aortic
blood flow patterns was confirmed in vivo by 4-D cardi-
ovascular magnetic resonance (CMR) visualization in
case reports involving BAV in association with a coarc-
tation [23] and in a case of BAV with ascending aortic
aneurysm [24]. Pathological changes in smooth muscle
cells and associated extracellular matrix protein expres-
sion have been found to be most significant in the con-
vexity of the aorta, where wall stress due to abnormal
flow patterns is expectedly highest [25,26]. Local varia-
tions have been found in thickness and mechanical
properties of excised ascending aortas [27]. In BAV
patients the outer curvature had reduced elasticity and
AA wall thickness compared to subjects with tricuspid
aortic valves. Accordingly, both abnormal aortic blood
flow patterns and abnormal extracellular matrix protein
expression could have value as potential predictive tools
for clinical risk stratification.
This paper reports on a prospective CMR study to
define quantifiers of abnormal aortic blood flow patterns
in a group of pediatric BAV patients, in comparison to
normal control subjects in the same age range. The
main purpose of the study is to investigate the hypoth-
esis that more eccentric systolic aortic flow jets in BAV
patients are associated with more dilated aortic dimen-
sions. The study was motivated by the need for a robust
risk stratification protocol for development of clinically
significant complications in pediatric BAV patients. Sup-
port for the stated hypothesis could help justify more
extensive investigation of blood flow phenomena in this
context. The same motivation also prompted us to add
to the experimental protocol a confirmatory investiga-
tion of serum levels of Matrix Metalloproteinases (speci-
fically MMP2 and MMP9) and associated tissue
inhibitors (specifically TIMP1 and TIMP2). MMPs are
associated with various forms of vascular remodeling
[28-32], and are readily quantified by commercially
available assays. Serum levels of MMP and TIMP have
been shown altered in BAV [33], especially with severe
aortic dilatation [34], and thus may be investigated as
potential low-cost, non-specific biomarkers of vessel
wall injury in BAV.
Methods
Time-resolved structural and 3-D velocity-encoded
CMR images were visualized jointly to create a dynamic
3-D view of blood flow patterns as vector fields in an
anatomical context using CMR techniques similar to
those explored previously for observation of blood flow
patterns in the great arteries [35-40], brain [41] and
abdomen [23,42]. First we calculated the expected ideal
systolic flow jet direction vector, measured as the aortic
channel direction in structural CMR images of the left
ventricular outflow tract (LVOT). Subsequently the
actual direction vector of the flow jet was determined
from the flow velocity data as the average systolic peak
forward flow direction. The resultant angle between
these two direction vectors represents a quantitative
measure of misdirected blood flow. This angle was cor-
related with aortic dilatation at four commonly used
anatomical levels: the aortic valve plane (AOV), sinus of
Valsalva (SOV), sinotubular junction (STJ), and the
ascending aorta (AAO). In addition, for the BAV
patients in our study, aortic dilatation and misaligned
blood flow were also correlated with plasma levels of
the extracellular matrix proteins MMP-2, MMP-9,
TIMP-1 and TIMP-2, which have been previously pro-
posed by other investigators as non-imaging markers of
vessel wall disease [29-32].
Study Population
From October 2006 until July 2008 a total of 18 asymp-
tomatic BAV patients and 11 healthy control subjects in
the age group 10-18 years were recruited and successfully
underwent CMR. All subjects gave informed consent/
assent per IRB-approved protocol. Patient exclusion cri-
teria were: systemic hypertension for age and height,
treatment with cardiac or vasoactive medications, sub-
jects suffering from possibly confounding conditions
such as connective tissue diseases including Marfan or
Turner syndrome, greater than mild aortic stenosis
(defined by a mean gradient by Doppler echocardiogra-
phy of ≥ 17 mmHg), more than mild aortic regurgitation
(defined by a regurgitant jet resulting in a left ventricular
end-diastolic dimension >2 standard deviations above the
mean for body surface area (BSA), or the presence of
pan-diastolic retrograde flow on pulsed Doppler evalua-
tion of the abdominal descending aorta). One control
subject was found to have dilatation of the ascending
aorta, considered unrepresentative of the normal pedia-
tric population, and was excluded from analyses. General
patient characteristics are summarized in Table 1.
CMR
All subjects underwent a single non-contrast CMR
which included structural and phase velocity-encoded
imaging of the left ventricular outflow tract (LVOT) and
ascending aorta. Structural breath-held SSFP ciné
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Page 2 of 13images were acquired on a GE Signa Twinspeed 1.5 T
scanner, running Release 12M4. Scan parameters for the
FastCINE/FIESTA pulse sequence included TR = 4 ms,
TE = 2 ms, flip angle 45 degrees, typical FOV 300-350
mm, 128-192 phase encodings, RFOV 70-100%, recon-
struction matrix 256 × 256, pixel BW 1 kHz, VPS = 8-
12 (eff. temporal resolution 32-48 ms), 20 cardiac phases
reconstructed using retrospective VCG gating, 1 slice
acquired per breath-hold, ASSET parallel imaging accel-
eration used as SNR allowed, acquisition time 6-14 s/
slice. Views included an oblique sagittal LVOT view
(Figure 1A), an oblique coronal LVOT view (Figure 1B),
a candy-cane view centrally through the aortic arch (Fig-
ure 1C), and views perpendicular to the aorta at the
levels of AOV plane (Figure 1D), mid-SOV, STJ, and a
more distal view through the mid-AAO. Time-resolved
flow velocity encoded imaging was performed in breath-
hold mode, using a FastCINE PC protocol with typical
parameters TR = 12 ms, TE = 4 ms, flip angle 20
degrees, FOV 350 mm, RFOV 70%, 96-128 phase encod-
ings, reconstruction matrix 256 × 256, pixel BW 125 Hz,
VPS = 4-6, velocity encoding with VENC = 200 cm/s in
all three dimensions (eff. Temporal resolution 192-288
ms), reconstructed at 20 time points in the cardiac
cycle. Maxwell correction for concomitant gradient
effects and gradient warp correction were performed by
the GE scanner reconstruction software. Seven to ten
equidistant parallel 2-D slice planes were scanned per-
pendicular to the valve plane, each acquired within a
breath-hold interval with 3-D phase velocity encoding.
The 7-9 mm thick slices, spaced 8-10 mm, cover the
ascending aorta from just beneath the aortic valve plane
into the transverse arch. 4-D flow imaging data allow
better spatial and temporal resolution than FastCINE
PC slice flow data. Therefore a 4-D flow scan[38,43] was
also acquired on all subjects. However due to ethical
concerns no gadolinium contrast was used in this study,
and without contrast these scans suffer from poor con-
trast and SNR. For this reason these data were not used
in this study.
Image Analysis and Visualization
Dynamic structural images and blood flow velocity pat-
terns were visualized using the in-house developed
Heartviz/Flowviz 3-D software. Example visualizations
are shown in Figure 2. Aortic regions of interest (ROI)
were identified in structural images and visualized
jointly with the corresponding blood flow velocities,
reconstructed from velocity-encoded images, and dis-
played as dynamic vector arrow fields.
Aortic Blood Flow Direction
Time points of systole and diastole were determined by
observation of dynamics of cardiac contraction and
blood flow. A vector representing direction and velocity
of the peak systolic blood flow jet was calculated by
averaging of flow vectors in all forward flow pixels
inside the aorta (defined by manual ROI tracing in the
associated image) in a slice located centrally in the
sinuses of Valsalva at peak systole. Figure 3A shows sys-
tolic pixel flow vectors in six slices for a BAV patient,
and Figure 3B shows the mid-SOV slice used for calcu-
lation of the flow jet direction, with the flow vectors
amplified compared to (3A). A second vector represent-
ing the axis of the LVOT at systole was calculated from
manually defined landmarks indicating the proximal
valve plane and the sino-tubular ridge in the most cen-
tral slices of the two orthogonal views of the LVOT
(Figure 3C and 3D). The angle between the blood flow
jet vector and the outflow tract axis, proposed as a
quantitative parameter of mis-directed valvular flow, was
then calculated from these vectors (Figure 3E).
Aortic diameter measurements
Aortic diameters were measured at the AOV, SOV, STJ
and AAO during peak systole. At each location the lar-
gest observed perpendicular cross-sectional diameter was
used for analysis. For diameters at the level of AOV,
SOV, and STJ axial images at t hose locations were ana-
lyzed, angled perpendicular to the aorta (Figure 1D). The
maximum diameter in the AAO was determined as the
largest cross-section observed perpendicular to the aortic
axis curve in a mid-vessel slice in the “candy-cane” view
(Figure 1C), distal to the STJ and proximal to the branch
of the brachiocephalic trunk. For statistical analysis all
aortic diameters were corrected for Body Surface Area
(BSA) by dividing diameters by the square root of the
BSA (Haycock formula [44]).
MMP 2, 9 and TIMP 1, 2 plasma measurements
From the BAV patients blood samples were obtained
prior to CMR from peripheral veins and collected in
Table 1 Baseline characteristics of BAV patients and
control subjects.
Characteristic BAV patients Controls p-value
N1 8 1 0
Age 15.7 +/- 1.9 14.2 +/- 2.6 0.10
BSA 1.7 +/- 0.30 1.7 +/- 0.31 0.87
male 72.2 % (n = 13) 70 % (n = 7) 0.87
female 27.8 % (n = 5) 30 % (n = 3)
Characteristic BAV Patients
Aortic dilatation 14
Aortic aneurysm 0
Left/right cor. cusp fusion: 15
Right/non-cor. cusp fusion 3
Left/non-cor. cusp fusion 0
Standard deviations in the observed values are listed with subject age and
BSA. P-values show no significant differences in estimated mean values
between patients and controls.
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Figure 1 Structural CMR images used in image analysis: (A) an “LVOT1” orthogonal view centrally in the LVOT, (B) a second
orthogonal “LVOT2” view, (C) a “candy-cane” view of aortic arch, and (D) a systolic mid-SOV level view of valve leaflets. Figures (A,B)
are used to calculate the aortic channel direction, (C) illustrates AAO size measurement, and (D) illustrates how aortic sizes are measured at the
levels of AOV, SOV, and STJ.
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control subjects in this preliminary study for reasons of
ethics and recruitment logistics. Plasma was separated
by centrifugation at 3300 rpm for 10 min at 4°C and
immediately frozen and stored at -80°C. Plasma MMP2,
MMP9, TIMP1 and TIMP2 levels were determined by
two-site enzyme-linked immunosorbent (ELISA) assays
using commercially available kits with monoclonal anti-
bodies against the proteins (Amersham Human Biotrak;
GE healthcare Bio-Sciences, Piscataway, NJ). The assays
measured total MMP 2, MMP 9 and TIMP1 and TIMP
2 levels in the samples. All samples were run in dupli-
cate and results were averaged.
Statistics
Distribution characteristics are presented as mean +/-
standard error of the mean, unless otherwise noted. Dis-
tributions were tested for normality using Q-Q plots
and the Shapiro-Wilk test. Group comparisons between
BAV patients and controls used the unpaired Student’s
t-test. Pearson’s correlation coefficients were used to
determine correlations between normal distributions.
Spearman’s non-parametric rank correlation coefficients
were used for very small samples and non-normally dis-
tributed populations.
Prior to all correlation analyses data were screened on
multivariate outliers using informal identification in
scatter plots and calculation of Mahalanobis distance.
Outliers were not removed from data. All tables indicate
the number of subjects on which results are based.
Intra-observer variability in aortic dimension and flow
angle measurements was calculated by evaluation of
duplicate measurements by the same observer. Inter-
observer variability was calculated by evaluation of the
same measurements by two observers. These measure-
ment sets were evaluated for the entire study popula-
tion, and thus represent the entire encountered range of
A  B 
C  D 
Figure 2 3-D reconstructions of aortic blood flow during peak systole (A,B) in a normal subject with tricuspid aortic valve, showing a
centrally directed systolic flow jet, and (C,D) in a BAV patient with aortic dilatation, showing anteriorly directed off-axis systolic flow.
The images in each pair of views mutually cross-reference the location of the perpendicular slice by the color of the intersection lines. The
intersection line is ideally located along the LVOT channel axis but this scan planning does not necessarily work out perfectly in all cases, so in
the analyses this direction is recalculated (see Figure 3).
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concordance correlation coefficients (CCC) [45], the
estimated standard deviation, and where appropriate,
the associated coefficient of variation (CV), and Bland
Altman 95% confidence limits of agreement [46].
Statistics were evaluated using Microsoft Excel 2003
(Microsoft, Redmond, WA) and SPSS 16.0 for Windows
(SPSS Inc., Chicago, Illinois). A p-value < 0.05 was con-
sidered to establish statistical significance.
Results
Characteristics of all BAV patients and control subjects
are summarized in Table 1. The gender distribution in
the study was consistent with the approximately 2:1
male predominance of BAV found in literature [9]. No
significant group differences were found in BSA or age
between patients and controls. Fifteen of the 18 BAV
patients had a fusion of the left and right coronary
cusps, 3 had a fusion of the right and non-coronary
cusps, and none had a fusion of the left and non-coron-
ary cusps; 14 patients had a diagnosed dilated ascending
aorta (defined as >2 standard deviations above normal
size in echo, BSA-adjusted); None had a diagnosed aor-
tic aneurysm (commonly defined subjectively as having
BSA-adjusted size 50% above normal [47]), one had
stable mild aortic regurgitation, one had a small apical
muscular ventricular-septal defect, and one had sus-
pected mild sinus node dysfunction. None of the com-
plications warranted exclusion of the subject.
Aortic diameters
Comparison of aortic diameters, corrected for BSA,
revealed that on average BAV patients had a statistically
A  B 
C  D  E 
Figure 3 Image analysis for calculation of the systolic flow jet angle: (A) 3-D view showing systolic flow velocity vectors in all slices.
(B) Systolic flow jet velocities in the central-most slice in the SOV, which are averaged to determine the flow jet direction (orange in E); (C,D)
show the aortic channel direction definitions in the LVOT views. Line segments 1-2 and 3-4 in the LVOT1 view (A) and a-b and c-d in the LVOT2
view (B) are manually drawn to connect the proximal and distal boundaries on both sides of the SOV, which are easily detected landmarks. The
vector average of each segment pair defines the projection of the outflow channel direction onto each image plane. These two projections are
then used to calculate the channel axis (light blue in E) for calculation of the angle between the flow jet direction vector and channel axis,
which quantifies the mis-direction of systolic flow.
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AAO compared to controls (Figure 4, Table 2). The differ-
ence in diameter at the level of the AOV approached sta-
tistical significance. We found that the aortic diameters
were normally distributed at all four levels.
The inter- and intra-observer variability for diameter
measurements is summarized in Table 3. Reproducibility
of the aortic size parameters was generally excellent, with
CCC values all above 0.89, and coefficients of variation
ranging between 2.3 and 5.1%. Bland Altman plots and
scatter diagrams for reproducibility of the ascending
a o r t aa r es h o w ni nF i g u r e5 .B l a n dA l t m a na n a l y s i s
shows in all cases confidence intervals that include zero,
indicating absence of evidence of observer bias.
Direction of Systolic Aortic Flow Jet
T h ea v e r a g ea n g l eb e t w e e nt h es y s t o l i cb l o o df l o wj e t
direction at the level of the AOV and the left ventricular
outflow tract axis was significantly larger in BAV
patients as a group (17.54 +/- 0.87 degrees) than in con-
trol subjects (10.01 +/- 1.29 degrees, p = 0.01) (Table 2).
The distributions of angle measurements passed the test
of normality.
The blood flow jet angle and aortic diameter showed
significant r-values in BAV patients (Table 4) at the level
of the STJ (p = 0.048) and the AAO (p = 0.022) but
r-values were not significant in correlations with aortic
dimensions at any level in control subjects (Table 5).
If eccentric systolic blood flow causes dilatation, such
an effect may manifest regardless of the immediate
cause of such flow patterns, and may thus not be limited
to BAV subjects. When BAV patients and control sub-
jects were combined into one group (Table 6), the blood
flow jet angle was indeed more strongly correlated to
aortic diameters. In the pooled populations we found
significant r-values at the levels of the SOV (p = 0.023),
STJ (p = 0.014) and AAO (p = 0.001). Figure 6 further
s h o w ss c a t t e rd i a g r a m so ft h ed i s t r i b u t i o n sf o rB A V
patients and controls at all four levels.
The inter- and intra-observer variability for flow jet
angle measurements is summarized in Table 3. Intra-
and inter-rater reproducibility of the flow jet angle was
good, with CCC values of 0.946 and 0.960, respectively.
The average flow angle was 13.7 degrees, and estimated
standard deviations in repeat measurements of 1.64
degrees (intra-rater) and 1.38 degrees (inter-rater),
resulting in CV values of 12.0% and 10.2%, respectively.
The Bland Altman analysis is illustrated in Figure 7.
Plasma protein levels
Plasma samples were collected from all 18 BAV patients
and MMP2, MMP9, TIMP1 and TIMP2 plasma levels
Figure 4 Comparison of mean flow jet angle and aortic diameters, adjusted for BSA, between BAV patients and control subjects.
Errors bars indicate two standard errors of the mean.
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concentration was 1387.5 +/- 82.4 ng/ml, mean MMP9
concentration was 8.85 +/- 1.6 ng/ml, TIMP1 concen-
tration was 268.9 +/- 13.8 ng/ml and mean TIMP2 con-
centration was 80.3 +/- 7.1 ng/ml.
Except for TIMP1 none of the distributions of con-
centration measurements passed the test for normality.
For this reason correlations between protein levels and
aortic diameters were determined using non-parametric
Spearman’s correlation coefficients. MMP 2 plasma
levels were significantly correlated to aortic diameter at
the level of the AAO (r = 0.512, P = 0.025) and
approached significant correlations at the levels of the
SOV (Spearman rank r = 0.430, p = 0.066) and STJ (r =
0.444, p = 0.057). TIMP2 plasma levels correlated signif-
icantly to aortic diameter at the level of the STJ (r =
0.570, p = 0.011) and moderately at the level of the
SOV (r = 0.458, p = 0.049). MMP9 and TIMP1 plasma
concentrations were not correlated to aortic diameter at
any anatomical level.
Plasma MMP2 levels were moderately correlated to
blood flow jet angle (Spearman r = 0.509, p = 0.044).
No significant correlation was observed between blood
flow jet angle and MMP9 or TIMP1 and TIMP2 plasma
levels.
Discussion
We found significant correlations between the blood
flow jet angle, representing a quantitative measure of
misdirected blood flow, and aortic diameters at the level
of the SOV, STJ and AAO. The significantly positive
correlation coefficients suggest that the larger the angle
of misdirected flow with the aortic axis, the larger aortic
diameter and thus the more severe the observed dilata-
tion is. These results favor the hypothesis that abnormal,
misdirected blood flow patterns associated with BAV are
directly implicated in the development of aortic dilata-
tion and that dilatation is not solely a manifestation of a
connective tissue disease as some investigators have pro-
posed [48]. Correlations are most significant at the more
distal level of the ascending aorta, where shear wall
stress and pressure are expectedly highest.
In addition to the flow data, we also found significant
correlations between aortic diameters and MMP 2 and
T I M P2b u tn o tM M P9a n dT I M P1p l a s m al e v e l si n
BAV patients. These results confirm previous studies
that demonstrated significantly increased tissue levels of
MMP 2 but not MMP 9 in aneurysms of BAV patients
compared to TAV patients [34,49,50], and our results
confirm an earlier study that reported a significant cor-
relation between aortic diameter and MMP 2 expression
[49]. In addition, by our best knowledge this study is the
first to also demonstrate a relation between TIMP 2
plasma levels and aortic diameter. Although it remains
Table 2 Mean diameters at all 4 aortic levels in BAV
patients and control subjects, adjusted for BSA.
BAV Controls
N Mean Mean/
√BSA
N Mean Mean/
√BSA
p-
value
AOV
(mm)
18 27.95 +/-
1.06
21.40 +/-
0.75
10 24.71 +/-
1.15
19.05 +/-
0.76
0.054
SOV
(mm)
18 33.17 +/-
1.09
25.44 +/-
0.79
10 29.01 +/-
0.77
22.48 +/-
0.81
0.022
STJ
(mm)
18 28.90 +/-
1.00
22.09 +/-
0.63
10 25.59 +/-
1.25
19.69 +/-
0.67
0.022
AA
(mm)
18 30.79 +/-
1.18
23.31 +/-
0.78
10 22.96 +/-
1.26
17.15 +/-
0.65
<0.001
ANGLE
(°)
18 17.54 +/-
0.87
10 10.01 +/-
1.29
0.01
Given are standard errors of the mean. Significance p-values reflect
differences in mean BSA-adjusted diameter between BAV patients and control
subjects.
Table 3 Reproducibility statistics for intra-rater and inter-
rater variations in measured aortic diameters and flow
angles.
Intra-Rater
Mean
Value
(mm)
Mean
Stddev
(mm)
CV
(%)
CCC Bland Altman 95%
confidence interval
of difference (mm)
AOV 23.74 1.17 4.6% 0.926 [-2.59,3.91]
SOV 30.32 0.98 3.2% 0.949 [-2.44,3.00]
STJ 27.42 0.67 2.6% 0.970 [-2.14,1.59]
AA 27.91 0.67 2.3% 0.988 [-1.89,1.79]
Mean
Value
(degrees)
Mean
Stddev
(degrees)
CV
(%)
CCC Bland Altman 95%
confidence interval
of difference
(degrees)
FLOW
ANGLE
13.7 1.64 12.0% 0.946 [-4.34,4.77]
Inter-Rater
Mean
Value
(mm)
Mean
Stddev
(mm)
CV
(%)
CCC Bland Altman 95%
confidence interval
of difference (mm)
AOV 23.74 1.33 5.1% 0.893 [-4.94,2.45]
SOV 30.32 1.23 3.9% 0.914 [-4.17,2.62]
STJ 27.42 1.00 3.8% 0.910 [-3.76,1.79]
AA 27.91 0.86 3.0% 0.977 [-1.97,2.78]
Mean
Value
(degrees)
Mean
Stddev
(degrees)
CV
(%)
CCC Bland Altman 95%
confidence interval
of difference
(degrees)
FLOW
ANGLE
13.7 1.38 10.2% 0.960 [-3.40,4.23]
Data are based on 2 repeat measurements in all (25) subjects. The table gives
the estimated standard deviation in repeat measurements based on pair-wise
differences, the mean corresponding coefficient of variation, the concordance
correlation coefficient{Lin, 1989 #188}, and Bland Altman confidence intervals
{Bland, 1986 #246}.
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and TIMP 2 plasma levels are a cause or a result of aor-
tic dilatation, the results indicate that MMP levels and
fluid-mechanical forces due to abnormal flow patterns
both play a role in the development of vessel wall dis-
ease. More extensive studies will be needed to deter-
mine the weight of these important causal contributors
to aortic dilatation.
The hypothesis of a direct relation between abnormal
flow patterns and aortic dilatation is consistent with our
observations that the correlation between the blood flow
jet angle and aortic diameter is stronger when BAV
patients and control subjects are pooled into a single
population. A hypothesized effect of dilatation as a result
of eccentric systolic blood flow need not necessarily be
specific to BAV subjects, but may occur similarly in other
individuals with similarly disturbed flow, and absent in any
subjects with well-aligned flow patterns. In this respect it
is a logical step to consider both groups as different classes
within one population, who are all subject to this same
effect. With the relatively small number of subjects
included in the present study significant correlations were
found at 2 of 4 levels of the aorta when observing BAV
patients alone. The normal population alone mostly has
normal flow, hence lower spread in aortic sizes, and thus
shows no correlation. Pooling the normal control subjects
and the BAV population will show larger numbers as well
as an increased range of both phenomena, evidenced by a
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Figure 5 Bland Altman plots (a,b) and scatter diagrams (c,d) illustrating the intra- and inter-rater variability in ascending aorta size
evaluations.
Table 4 Pearson correlations between blood flow jet
angle and aortic diameter at the indicated aortic levels
in BAV patients only.
N r-value p-value
AOV 18 0.000 0.999
SOV 18 0.386 0.114
STJ 18 0.472 0.048*
AA 18 0.536 0.022*
An asterisk marks statistical significance at the 95% probability level.
Table 5 Pearson correlations between blood flow jet
angle and aortic diameter at the indicated aortic levels
in control subjects only.
N r-value p-value
AOV 10 -0.129 0.999
SOV 10 -0.378 0.282
STJ 10 0.377 0.283
AA 10 0.243 0.498
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Page 9 of 13stronger correlation, which is now significant at 3 out of 4
levels of the aorta. Again larger studies in a wider age
range are required to actually determine cause and effect
and to differentiate between BAV patients at risk for rapid
aortic dilatation and lower-risk slow progressors. The
causality question may of course not be straightforward to
answer, since it is well-known that BAV is also associated
with connective tissue disease [33,51,52]. Both these (and
likely also other) factors may in actuality play a causal role.
Should a causal link between misdirected blood flow
and severity of aortic dilatation be confirmed, a combi-
nation of imaging tests and protein assays may be envi-
sioned for use in a BAV management protocol to allow
for clinical risk monitoring of BAV patients. For
instance, regular sampling of plasma levels of extracellu-
lar matrix proteins in previously diagnosed BAV may be
used as an indication of the presence of vessel wall
injury. In this population such a finding puts the
immediate suspicion on injury localized in the aorta,
and imaging tests may be indicated in patients with con-
sistently elevated plasma levels to diagnose dilatation,
and/or risk for accelerated dilatation if highly abnormal
flow patterns are observed. Clinical risk stratification of
BAV patients is much desired considering the variation
in development and progression of aortic dilatation and
the increased risk for serious complications including
sudden cardiac death [18-20]. Detailed analysis of
abnormal blood flow patterns and MMP 2 plasma levels
of extracellular matrix proteins may enable earlier, bet-
ter, and individually tailored intervention in high-risk
groups with an anticipated reduction in morbidity and
mortality within this important class of congenital
malformations.
Limitations of the Study
Due to the relatively small number of samples and lack
of age stratification in our data the results do not yield
insight into whether misdirected flow patterns are a
Table 6 Pearson correlations between blood flow jet
angle and aortic diameter at the indicated aortic levels.
N r-value p-value
AOV 28 0.159 0.420
SOV 28 0.405 0.033*
STJ 28 0.562 0.002**
AA 28 0.645 <0.001**
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Figure 6 Scatter diagrams showing distribution systolic blood flow jet angles of aortic outflow as a function of aortic diameters,
corrected for BSA, and at the level of the aortic valve (A), sinus of Valsalva (B), sinotubular junction (C) and ascending aorta (D).
Regression lines are shown of line fits with all subjects combined. An asterisk with the Pearson correlation coefficient in the figure legend
indicates a statistically significant correlation.
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Page 10 of 13cause or a consequence of aortic dilatation. This preli-
minary study aimed at investigating 3-D CMR flow ana-
lysis as a promising discriminating test for at-risk
patients. Despite the small sample some important sig-
nificant correlations were elucidated, but a larger study,
spanning a more complete spectrum of ages and flow
patterns, and aortic dimensions, will be required to
investigate causality of these phenomena.
Another limitation of the study is the relatively sim-
plistic and naïve quantification of abnormality the aortic
flow jet by calculation of the flow angle. The flow jet
angle, investigated in this work, quantifies mis-direction
of aortic flow, presumably due at least in part by incom-
plete opening of the aortic valve. While this phenom-
enon is readily observed and quantified by velocity-
encoded CMR as we have shown in this paper, it only
quantifies an important but limited and simple aspect of
the relevant fluid mechanics at work. More complete
and sophisticated characterization of the hemodynamic
stresses and forces acting on the aorta in this (and
other) congenital disease are quite challenging from
aspects of both mathematics and imaging technology.
Increasing availability of 4-D flow imaging methods on
commercial platforms, along with emerging research
thrusts integrating CMR flow data with computational
flow modeling, are anticipated to further improve on the
accuracy and precision of the ad-hoc methods employed
in this early investigation. We believe that combination of
computational fluid modeling and 4-D blood flow CMR,
although currently still in an early stage of development,
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Figure 7 Bland Altman plots (a,b) and scatter diagrams (c,d) illustrating the intra- and inter-rater variability in flow angle evaluations.
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Page 11 of 13carries great potential to contribute important new knowl-
edge and answers to many important questions involving
blood flow in congenital heart disease.
Conclusions
In conclusion, the results of this study suggest that
abnormal flow patterns, abnormal protein expression and
aortic dilatation are all directly related in BAV patients.
Our findings support the hypothesis that both factors are
acting simultaneously in the development of dilatation
[49]. Despite small numbers of subjects significant corre-
lation was established in our data between the systolic
LV outflow jet angle with the aortic root channel and
dilatation at the levels of the sinus of Valsalva, sinotubu-
lar junction, and the ascending aorta. Significant correla-
tion was observed of plasma levels of MMP 2 with
dilatation at the ascending aorta level, and with the flow
jet angle. Although it remains inconclusive from this
study whether abnormal aortic flow patterns and extra-
cellular matrix protein expression are a cause or a conse-
quence of aortic dilatation, this study illustrates the
potential future use of plasma biochemical markers as
non-specific screening parameters, and quantitative ima-
ging metrics of abnormal 3-D blood flow imaging as pos-
sible localized predictors for aortic dilatation.
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